Alzinova
Manufacturing · Sweden · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Entreprenörsstråket Goco House 10, Mölnd...Website
www.alzinova.comRevenue
<$5 MillionStock Symbol
ALZ.STIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Alzinova
Alzinova AB is a Swedish clinical-stage biopharmaceutical company dedicated to combating Alzheimer's disease by developing novel immunotherapies. With its proprietary 'AβCC Peptide Technology,' the firm works on precision medicines targeting neurotoxic amyloid-β oligomers—offering the potential to modify disease progression and help patients lead more independent and active lives.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Alzinova your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Alzinova is spiking on competitors!
Funding: Get notified immidiatlly once Alzinova has new funding data
Check if Alzinova has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Alzinova
Click to see if Alzinova had a recent Job posting/layoffs
Earning: See what the market has to say on Alzinova recently announced quarterly report
Alzinova, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Alzinova launches new products
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Alzinova is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Alzinova is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Alzinova.
Alzinova financials insights
Gather financial insights about Alzinova, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Stock Offering
$579K
2025
Debt
$1.2M
Alzinova Tech Stack
A closer look at the technologies used by Alzinova
See more technologies
Most Recent Scoops
Funding
Funding
Left Company
Executive Move
Executive Moves, Left Company
Left Company
Executive Move
Executive Moves, Left Company
New Hire
Executive Move
Executive Moves, New Hire
Left Company
Executive Move
Executive Moves, Left Company
Alzinova News & Media
Alzinova strategically realigns CMO position to enhance collaboration and drive next ... - Placera
Alzinova AB (publ) (ticker: ALZ) hereby announces that the Company's CMO is stepping down from her role after mutual agreement. The basis is a strategic decisioAlzinova’s new CEO to BioStock: “The next six months will be really exciting”
Tord Labuda has entered the role as CEO of Alzinova, bringing extensive experience from leading positions in the pharmaceutical industry. The company is in an exciting development phase, as the clinical phase Ib study with the Alzheimer’s vaccine ALZ-101 is expected to be completed in early 2025. In preparation for phase II, Alzinova is actively exploring opportunities for licensing agreements with a larger pharma company. Read the full interview with Tord Labuda at biostock.se: https://www.biosAlzinova appoints Erik Kullgren as interim CFO — TradingView News
Alzinova AB (publ) (ticker: ALZ) today announces that the company appoints Erik Kullgren as interim CFO due to the fact that the company's current CFO, Håkan Skogström, will retire on March 27. The process of recruiting a permanent CFO is ongoing.Alzinova has previously announced that CFO Håkan Sko…Alzinova AB interim report January – September 2022
The Board of Directors and the Chief Executive Officer of Alzinova AB hereby present the interim report for the period January - September 2022 Three months, July – September 2022 · Net sales amounted to 0 SEK (0 SEK). · Result after financial items amounted to SEK -2,771,286 (SEK -1,455,142). · Earnings per share amounted to SEK -0.09 (SEK -0.09). Nine months, January – September 2022 · Net sales amounted to 0 SEK (0 SEK). · Result
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Alzinova
Sign Up For FreeTo access detailed company insights
Alzinova AB is a Swedish clinical-stage biopharmaceutical company dedicated to combating Alzheimer's disease by developing novel immunotherapies. With its proprietary 'AβCC Peptide Technology,' the firm works on precision medicines targeting neurotoxic amyloid-β oligomers—offering the potential to modify disease progression and help patients lead m... Read More
